Department profile
Morgan, Lewis & Bockius LLP

Corporate/M&A

USA Guide 2026 : New Jersey


Morgan, Lewis & Bockius LLP

Rankings

About

Provided by Morgan, Lewis & Bockius LLP

We work on a broad range of global mergers and acquisitions. Our team counsels sellers and buyers, investors and owners, boards of directors, and sources of financing and intermediaries, including private equity and venture capital funds. We help secure transaction financing, working with investment and commercial banks and other institutional lenders, and we advise entity-level decisionmakers, counseling boards, independent director committees, and management groups in myriad regulated and unregulated industries around the world. Our transactions have ranged in value from a few million dollars to more than $70 billion.

Our team can handle any issues arising from a merger, acquisition, or divestiture, whether environmental, labor, employment, and compensation matters or government contracts, regulatory obligations, intellectual property rights, and tax matters. We help clients negotiate purchase and divestiture agreements, tender offers, restructurings, joint ventures, spin-offs, leveraged buyouts, and public-to-private transactions, and acquire distressed assets. We also advise public company targets and would-be acquirers regarding implementing or overcoming takeover defense mechanisms.

Chambers Review

Provided by Chambers

Corporate/M&A - New Jersey

Band 2

Band 2


What the Team is Known For
Morgan, Lewis & Bockius LLP possesses a strong group with an enviable life sciences, pharmaceutical and technology practice. It displays considerable strength in M&A and private equity transactions for a wide range of high profile medical device and pharmaceutical clients. It is particularly adept at brokering strategic collaboration agreements between pharma companies worldwide. The team is also able to advise on the full range of securities matters.

Work Highlights

Provided by Chambers

  • Morgan, Lewis & Bockius LLP advised Contentstack on its acquisition of Lytics.

Strengths

Provided by Chambers

  • The attorneys have always been extremely helpful and responsive with the highest of service level and professionalism.

    Corporate/M&A respondentUSA
  • The attorneys are very client-focused, extremely responsive, solution-oriented and give good advice.

    Corporate/M&A respondentUSA
  • Morgan Lewis offers really strong client communication. They were really experienced and knowledgeable on the subject matter.

    Corporate/M&A respondentUSA

Notable Practitioners

Provided by Chambers

  • Band 2Steven Cohen
    Band 2Steven Cohen

    Steven Cohen

    Steven Cohen represents technology, pharmaceutical and hardware companies in a broad range of strategic transactions, including acquisitions, financing and restructuring. He is chair of the emerging business and technology practice.
  • Band 4David Schwartz
    Band 4David Schwartz

    David Schwartz

    David Schwartz's experience includes advising pharmaceutical and biotech companies on M&A and a range of financing matters, including public offerings and loans.
    • David Schwartz is an exceptional attorney. He's extremely knowledgeable and responsive.

      Corporate/M&A respondentUSA
  • Band 5Benjamin David Novak
    Band 5Benjamin David Novak

    Benjamin David Novak

    Benjamin Novak primarily represents emerging growth companies in the life sciences and technology spaces. He also counts private equity firms and venture capital funds among his clientele.

Ranked Individuals at Morgan, Lewis & Bockius LLP (3)

New Jersey

Members

Provided by Morgan, Lewis & Bockius LLP

Morgan, Lewis & Bockius LLP has rankings in the following guides

What success is built on

Chambers is the leading data and intelligence partner for the legal sector.

Explore thought leadership